Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001982230 | SCV002214305 | likely benign | TP63-Related Spectrum Disorders | 2024-07-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005002692 | SCV002778477 | uncertain significance | ADULT syndrome; Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome; Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3; Limb-mammary syndrome; Rapp-Hodgkin syndrome; Split hand-foot malformation 4; Orofacial cleft 8; Premature ovarian failure 21 | 2024-06-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004746523 | SCV005350346 | uncertain significance | TP63-related disorder | 2024-05-21 | no assertion criteria provided | clinical testing | The TP63 c.1807G>C variant is predicted to result in the amino acid substitution p.Asp603His. This variant has been reported in an individual with bilateral complete cleft lip and palate, inherited from her clinically unaffected father (Leoyklang et al. 2006. PubMed ID: 16740912). This variant is reported in 0.060% of alleles in individuals of East Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |